Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tepha in $10.7m financing:

This article was originally published in Clinica

Executive Summary

Tepha, a developer of absorbable devices for therapeutic applications, has closed a $10.7m venture capital financing in a bid to support the development of its TephaFLEX biopolymer technology platform, which it licensed from Metabolix. The funding was led by the Vertical Group, and backed by Integra Ventures, Novartis Venture Fund and Westfield Life Sciences Fund. Cambridge, Massachusetts-based Tepha is currently working with several companies to incorporate the TephaFLEX into the development of other devices, such as surgical meshes, haemostats, intra-cardiac devices, absorbable stents, ligament and tendon repair devices and drug delivery systems. The firm has received US marketing clearances for its TephaFLEX absorbable and surgical mesh.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT048517

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel